KL and cancer: For instance, combining Kla inhibitors with immune checkpoint inhibitors, standard chemotherapy/targeted therapies, and drugs targeting key glycolytic enzymes may open up new avenues for overcoming drug resistance and immune evasion in cancer treatment.